Autochthonous case of Trichophyton indotineae in Kuwait

IF 2.2 4区医学 Q3 MYCOLOGY

Journal de mycologie medicale Pub Date : 2023-09-01 DOI:10.1016/j.mycmed.2023.101432

Yousef Dashti , Khaled Alobaid , Shahad Al-Rashidi , Maryam Dashti , Moustafa Hussain AbdulMoneim , Manar Al-Enezi , Nissrine Abou-Chakra , Karin Meinike Jørgensen

引用次数: 1

Abstract

Trichophyton indotineae is an emerging dermatophyte that has remarkable impact on public health worldwide. In addition to producing severe extensive skin lesions, this species is frequently resistant to terbinafine, used as a first line agent. As a result, the infection is often refractory, making treatment very challenging. The current report describes the first case of Trichophyton indotineae infection in Kuwait. The infected woman had no recent travel history. She failed to respond to several courses of antifungals, but finally responded to voriconazole. The report suggests that T. indotineae is under recognised, hence, active surveillance of dermatophytes is warranted.

查看原文本刊更多论文

科威特本土印度毛癣菌病例

印度癣毛癣菌是一种新兴的皮肤癣菌，在世界范围内对公众健康产生了显著影响。除了产生严重的广泛皮肤损伤外，该物种还经常对用作一线制剂的特比萘芬产生耐药性。因此，感染往往是难治性的，这使得治疗非常具有挑战性。本报告描述了科威特首例印度毛癣菌感染病例。这名受感染的妇女最近没有旅行史。她对几个疗程的抗真菌药物没有反应，但最终对伏立康唑有反应。该报告表明，印度癣菌的认识不足，因此有必要对皮肤癣菌进行积极监测。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal de mycologie medicale 医学-真菌学

CiteScore

5.10

自引率

2.80%

发文量

审稿时长

6-12 weeks

期刊介绍： The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology. The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses. Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity. JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered. Under no circumstances does the journal guarantee publication before the editorial board makes its final decision. The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.